Literature DB >> 18250427

Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation.

Ralf A Linker1, Niels Kruse, Stephanie Israel, Tao Wei, Silvia Seubert, Anja Hombach, Bettina Holtmann, Fred Luhder, Richard M Ransohoff, Michael Sendtner, Ralf Gold.   

Abstract

The neurotrophic cytokines ciliary neurotrophic factor and leukemia inhibitory factor (LIF) play a key role in neuronal and oligodendrocyte survival and as protective factors in neuroinflammation. To further elucidate the potential of endogenous LIF in modulating neuroinflammation, we studied myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in LIF knockout mice (LIF(-/-) mice). In the late phase of active myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis, LIF(-/-) mice exhibited a markedly milder disease course. The inflammatory infiltrate in LIF(-/-) mice was characterized by an increase in neutrophilic granulocytes early and fewer infiltrating macrophages associated with less demyelination later in the disease. In good correlation with an effect of endogenous LIF on the immune response, we found an Ag-specific T cell-priming defect with impaired IFN-gamma production in LIF(-/-) mice. On the molecular level, the altered recruitment of inflammatory cells is associated with distinct patterns of chemokine production in LIF(-/-) mice with an increase of CXCL1 early and a decrease of CCL2, CCL3, and CXCL10 later in the disease. These data reveal that endogenous LIF is an immunologically active molecule in neuroinflammation. This establishes a link between LIF and the immune system which was not observed in the ciliary neurotrophic factor knockout mouse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250427     DOI: 10.4049/jimmunol.180.4.2204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.

Authors:  Jingya Zhang; Yueting Zhang; Dipankar J Dutta; Azeb T Argaw; Virginie Bonnamain; Jeremy Seto; David A Braun; Andleeb Zameer; Fernand Hayot; Carolina B Lòpez; Cedric S Raine; Gareth R John
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

Review 2.  The role of the leukemia inhibitory factor receptor in neuroprotective signaling.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Pharmacol Ther       Date:  2017-08-19       Impact factor: 12.310

Review 3.  Promoting myelin repair and return of function in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Linnea Asp; Dipankar J Dutta; Kristina Navrazhina; Trinh Pham; John N Mariani; Azeb Tadesse Argaw; Carmen V Melendez-Vasquez; Gareth R John
Journal:  FEBS Lett       Date:  2011-08-18       Impact factor: 4.124

Review 4.  Targeting oligodendrocyte protection and remyelination in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Sean Mahase; Dipankar J Dutta; Virginie Bonnamain; Azeb T Argaw; Gareth R John
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

5.  Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.

Authors:  Johannes Stegbauer; De-Hyung Lee; Silvia Seubert; Gisa Ellrichmann; Arndt Manzel; Heda Kvakan; Dominik N Muller; Stefanie Gaupp; Lars Christian Rump; Ralf Gold; Ralf A Linker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

6.  The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Rodrigo Naves; Simer P Singh; Kevin S Cashman; Amber L Rowse; Robert C Axtell; Lawrence Steinman; John D Mountz; Chad Steele; Patrizia De Sarno; Chander Raman
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

7.  CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.

Authors:  Helena Slaets; Jerome J A Hendriks; Chris Van den Haute; Frea Coun; Veerle Baekelandt; Piet Stinissen; Niels Hellings
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

8.  Role of glial 14-3-3 gamma protein in autoimmune demyelination.

Authors:  De-Hyung Lee; Petra Steinacker; Silvia Seubert; Tanja Turnescu; Arthur Melms; Arndt Manzel; Markus Otto; Ralf A Linker
Journal:  J Neuroinflammation       Date:  2015-10-06       Impact factor: 8.322

9.  Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.

Authors:  Robert F Foronjy; Abdoulaye J Dabo; Neville Cummins; Patrick Geraghty
Journal:  BMC Immunol       Date:  2014-10-03       Impact factor: 3.615

10.  Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism.

Authors:  Melissa M Gresle; Estella Alexandrou; Qizhu Wu; Gary Egan; Vilija Jokubaitis; Margaret Ayers; Anna Jonas; William Doherty; Anna Friedhuber; Gerry Shaw; Michael Sendtner; Ben Emery; Trevor Kilpatrick; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.